X4 Pharmaceuticals, Inc. (XFOR) Net income 2016–2025
X4 Pharmaceuticals, Inc. (XFOR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$79.2MFY2025 · since FY2016: -$23.0M → -$79.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$79.2M | -111.5% |
| FY2024 | -$37.5M | +63.0% |
| FY2023 | -$101.2M | -7.8% |
| FY2022 | -$93.9M | -5.8% |
| FY2021 | -$88.7M | -42.8% |
| FY2020 | -$62.1M | -17.7% |
| FY2019 | -$52.8M | -58.7% |
| FY2018 | -$33.3M | -51.3% |
| FY2017 | -$22.0M | +4.3% |
| FY2016 | -$23.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice